Exponent Q3 Revenue Rises 12% to $153.1 Million

Exponent reported Q3 2026 revenue before reimbursements of $153.1 million, up 12% year over year. Net income was $30.9 million, or $0.64 per diluted share, versus $28.0 million, or $0.55, a year earlier; EBITDA was $45.0 million with a 29.4% margin.